NCT06037538Completed
User Evaluation of BGM JS200B
Evaluierung Des Blutglukose Monitoring Systems JS200B Der Firma TysonBio gemäß DIN EN ISO 15197:2015
Institut fur Diabetes Karlsburg GmbHClinicalTrials.govdiagnostic test
Study focus
- Disease/Condition
- Diabetes
- Drug/Device/Intervention
- blood glucose measurement by subject
- Study type
- Interventional
- Intervention type
- diagnostic test
Sponsor & location
- Primary sponsor
- Institut fur Diabetes Karlsburg GmbH
- Location
- Karlsburg, Germany
Timeline & enrollment
- Phase
- N/A
- Start date
- Apr 19, 2023
- End date
- May 23, 2023
- Enrollment
- 100 participants
Primary outcome
Analysis of system accuracy based on DIN EN ISO 15197
Summary
Performance Evaluation by the User of the Blood Glucose Monitoring System JS200B in
 accordance with DIN EN ISO 15197:2015
ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsOther specified diabetes mellitus without complications
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06037538
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06037538 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut fur Diabetes Karlsburg GmbH and is currently Completed. The study focuses on Diabetes. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.